Subgroup | Value | Reference | Statin | Control | Relative risk (95% CI) | p value | Heterogeneity | p value for heterogeneity |
---|---|---|---|---|---|---|---|---|
 |  |  | Event/total | Event/total |  |  |  |  |
Mean Age | > = 65 | 29,32-34 | 92/2913 | 145/2948 | 0.66 [0.51, 0.85] | 0.001 | 0% | 0.44 |
 | <65 | 24,25 | 10/480 | 16/477 | 0.63 [0.27, 1.47] | 0.283 | 3% | 0.31 |
Cardiovascular History | Yes | 29,34 | 82/1130 | 119/1160 | 0.67 [0.14, 3.22] | 0.012 | 0% | 0.53 |
 | No | 25,32 | 4/192 | 7/205 | 0.71 [0.54, 0.93] | 0.613 | 25.1% | 0.25 |
Baseline Creatinine | > = 1.5 | 25,29 | 19/333 | 30/339 | 0.64 [0.37, 1.12] | 0.120 | 0% | 0.34 |
 | <1.5 | 24,32,34 | 75/1422 | 111/1457 | 0.70 [0.53, 0.93] | 0.013 | 0% | 0.55 |
Baseline LDL Cholesterol | > = 3.0 | 24,25, 29,32,34 | 94/1755 | 141/1796 | 0.69 [0.53, 0.88] | 0.003 | 0% | 0.704 |
 | <3.0 | 33 | 8/1638 | 20/1629 | 0.40 [0.18, 0.90] | 0.027 | - | - |
LDL Cholesterol Lowering | > = 30% | 29,33 | 25/1924 | 49/1922 | 0.52 [0.33, 0.84] | 0.007 | 0% | 0.418 |
 | <30% | 24,25,32 | 12/625 | 22/636 | 0.55 [0.27, 1.13] | 0.104 | 0% | 0.505 |
Follow-up time | > = 3 | 24,29,32, 34 | 92/1708 | 140/1750 | 0.68 [0.53, 0.87] | 0.003 | 0% | 0.70 |
 | <3 | 25,33 | 10/1685 | 21/1675 | 0.59 [0.15, 2.27] | 0.443 | 36% | 0.21 |